Abstract
Purpose
The aim of this study was to evaluate the effect of povidone-iodine rectal disinfection and targeted antimicrobial prophylaxis in men undergoing transrectal ultrasound-guided prostate biopsy based on rectal swab culture results.
Methods
From January 2011 to December 2015, we studied differences in infectious complications in men who received povidone-iodine rectal disinfection with targeted antimicrobial prophylaxis and those who received empirical prophylaxis before transrectal ultrasound-guided prostate biopsy. Clinical variables including demographics, prior antibiotic, rectal swab culture results, povidone-iodine rectal cleansing, antibiotic prophylaxis, and infectious complications were evaluated. Patients were divided into three groups as follows: Group A received no povidone-iodine rectal cleansing but received empirical antimicrobial prophylaxis; group B received povidone-iodine rectal cleansing and empirical antimicrobial prophylaxis; and group C received povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis.
Results
Patients were divided into group A (n = 192; 13.2 %), group B (n = 579; 39.9 %), or group C (n = 679; 46.8 %). In groups A and B, all patients received fluoroquinolone antimicrobial prophylaxis. Group C patients received targeted antimicrobial prophylaxis according to antibiotic resistance of rectal flora, and 71.1 % of these received fluoroquinolone antimicrobial prophylaxis. Infectious complication rates were 3.6, 2.9, and 1.3 % in group A, group B, and group C, respectively. Incidences of acute prostatitis and bacteremia were significantly lower in group C (p = 0.041 and p = 0.049, respectively) than in the other groups.
Conclusions
In the era of quinolone resistance, the combination of povidone-iodine rectal cleansing and targeted antibiotic prophylaxis may reduce the rate of infectious complications.
Similar content being viewed by others
References
Bootsma AMJ, Pes MPL, Geerlings SE, Goossens A (2008) Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 54(6):1270–1286. doi:10.1016/j.eururo.2008.03.033
Zani EL, Clark OAC, Netto NR (2011) Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Db Syst Rev 5:CD006576. doi:10.1002/14651858.CD006576.pub2
Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data From SEER-Medicare. J Urol 186(5):1830–1834. doi:10.1016/j.juro.2011.06.057
Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, Loblaw DA, Trachtenberg J, Stanimirovic A, Simor AE, Seth A, Urbach DR, Narod SA (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1):S12–S17. doi:10.1016/j.juro.2012.11.015
Loeb S, van den Heuvel S, Zhu XY, Bangma CH, Schroder FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61(6):1110–1114. doi:10.1016/j.eururo.2011.12.058
Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL (2013) Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis 57(2):267–274. doi:10.1093/cid/cit193
Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy—should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18(6):575–581. doi:10.1111/j.1469-0691.2011.03638.x
Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, Murphy AB, Dielubanza E, Schaeffer AJ (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187(4):1275–1279. doi:10.1016/j.juro.2011.11.115
Liss MA, Chang A, Santos R, Nakama-Peeples A, Peterson EM, Osann K, Billimek J, Szabo RJ, Dash A (2011) Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 185(4):1283–1288. doi:10.1016/j.juro.2010.11.088
Roberts MJ, Williamson DA, Hadway P, Doi SAR, Gardiner RA, Paterson DL (2014) Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. Int J Antimicrob Agents 43(4):301–309. doi:10.1016/j.ijantimicag.2014.01.008
Siriboon S, Tiengrim S, Taweemongkongsup T, Thamlikitkul V, Chayakulkeeree M (2012) Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand. Urol Int 88(2):187–193. doi:10.1159/000335506
Tsu JHL, Ma WK, Chan WKW, Lam BHS, To KC, To WK, Ng TK, Liu PL, Cheung FK, Yiu MK (2015) Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum beta-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy. Urology 85(1):15–21. doi:10.1016/j.urology.2014.07.078
Duplessis CA, Bavaro M, Simons MP, Marguet C, Santomauro M, Auge B, Collard DA, Fierer J, Lesperance J (2012) Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 79(3):556–561. doi:10.1016/j.urology.2011.09.057
Naber KG, Roscher K, Botto H, Schaefer V (2008) Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents 32(2):145–153. doi:10.1016/j.ijantimicag.2008.03.014
Wolf JS, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179(4):1379–1390. doi:10.1016/j.juro.2008.01.068
AbuGhosh Z, Margolick J, Goldenberg SL, Taylor SA, Afshar K, Bell R, Lange D, Bowie WR, Roscoe D, Machan L, Black PC (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189(4):1326–1331. doi:10.1016/j.juro.2012.09.121
Ghafoori M, Shakiba M, Seifmanesh H, Hoseini K (2012) Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial. Iran J Radiol 9(2):67–70. doi:10.5812/iranjradiol.7561
Hwang EC, Jung SI, Seo YH, Jeong SH, Kwon DD, Park K, Kim JW (2015) Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study. Int Urol Nephrol 47(4):595–601. doi:10.1007/s11255-015-0931-2
Mosharafa AA, Torky MH, El Said WM, Meshref A (2011) Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology 78(3):511–514. doi:10.1016/j.urology.2011.04.064
Patel U, Dasgupta P, Amoroso P, Challacombe B, Pilcher J, Kirby R (2012) Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int 109(12):1781–1785. doi:10.1111/j.1464-410X.2011.10561.x
Acknowledgments
This study was supported by a Grant (HCRI 15 007-1) from the Chonnam National University Hwasun Hospital Institute for Biomedical Science.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study protocol was reviewed and approved by the institutional review board of the Chonnam National University Hwasun Hospital (IRB approved Protocol: No. CNUHH-2015-158). Informed consent was waived by the board.
Rights and permissions
About this article
Cite this article
Ryu, J.W., Jung, S.I., Ahn, J.H. et al. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications. Int Urol Nephrol 48, 1763–1770 (2016). https://doi.org/10.1007/s11255-016-1394-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-016-1394-9